Latest News
STAT+: Dear Vinay: Please embrace dissent and fade into the background
Vinay Prasad is back at the FDA, and in a position in which grappling with nuance — not always his strong suit — will be the key to his success.
STAT+: Peptide vaccine could limit pancreatic cancer progression, small study finds
A small study finds that an off-the-shelf vaccine candidate by Elicio Therapeutics boosted immune response in pancreatic cancer patients.
STAT+: Pharmalittle: We’re reading about Prasad’s return to FDA, a journal sparring with RFK Jr., and more
Plus more pharma news from the Pharmalittle newsletter.
STAT+: Health news from the weekend: A shooting at CDC, and a regulator returns to FDA
And other health news stories you need to read
STAT+: That was fast: Vinay Prasad is back at CBER
And other biotech news updates, brought to you by The Readout.
As use of telehealth for medication abortion grows, new data offer window into patient population
Prescriptions by a major provider suggest telehealth has "changed the abortion care landscape."
STAT+: After years of close mentorship, Harvard’s president and Jay Bhattacharya enter dramatic new territory
Alan Garber’s former student now holds the keys to Harvard’s future
STAT+: The Medicare Advantage research machine
This is the online version of STAT's weekly email newsletter Health Care Inc.
NIH director: mRNA vaccine contracts were canceled because public lacks trust in technology
NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with that of his boss, health se...
STAT+: Scientific panel puts new guardrails around stem cell-based embryo models
An influential scientific panel is pumping the brakes on stem cell-based embryo models.
STAT+: Dear Vinay: Please embrace dissent and fade into the background
STAT+: Peptide vaccine could limit pancreatic cancer progression, small study finds
STAT+: Pharmalittle: We’re reading about Prasad’s return to FDA, a journal sparring with RFK Jr., and more
STAT+: Health news from the weekend: A shooting at CDC, and a regulator returns to FDA
STAT+: That was fast: Vinay Prasad is back at CBER
As use of telehealth for medication abortion grows, new data offer window into patient population
STAT+: After years of close mentorship, Harvard’s president and Jay Bhattacharya enter dramatic new territory
STAT+: The Medicare Advantage research machine
NIH director: mRNA vaccine contracts were canceled because public lacks trust in technology
STAT+: Scientific panel puts new guardrails around stem cell-based embryo models
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago